Professional Documents
Culture Documents
Week 5. Covid-19
Week 5. Covid-19
GROUP 2
RLE NCMB 418
TABLE OF CONTENTS
01 02
Trace the Briefly, but thoroughly, describe and explain
pathophysiology of the each the laboratory and diagnostic
condition and course of procedures, including the relevance of each
her disease. in managing the patient.
03 04
Formulate a plan of care for
the patient focusing on
Discharge Plan
a. Prioritized needs
b. Anticipated needs
CASE SCENARIO: Young Peggy (Adapted from Case Reports in
Women’s Health, 2021)
A 30-year-old primiparous woman, Peggy, (BMI = 27.5 kg/m2) was referred to FUMC at
approximately 34 weeks of gestation because of a positive quantitative RT-PCR throat
swab for severe acute respiratory syndrome coronavirus. She has fever for 2 days
(average temp = 39.0°C) and saturation O2 (SpO2) was 95% (room air). A chest CT scan
revealed bilateral multifocal ground-glass opacities with partial consolidation,
corresponding to COVID-19 pneumonia. Admission laboratory data showed a WBC count
of 8800/μL, lymphocyte 12.4%, C-reactive protein (CRP) 3.54 mg/L, D-dimer 2.3μg/mL
(<1.0μg/mL), and IL-6487 pg/mL (<4.0). Ciclesonide inhalation 400μg/day,
dexamethasone 6.6 g/day, heparin sodium 10,000 U/day, and sulbactam/ampicillin 6
g/day were initiated.
On the second day after admission Peggy continued to have high fever with chills and
shivers; her dyspnea worsened. SpO2 was 95% with a 1-L/min oxygen flow via nasal
cannula. Remdesivir 200 mg/day and tocilizumab 8 mg/kg were administered on the
next day. On the fourth day after admission, her respiratory condition rapidly worsened,
and the SpO2 was 94%–95% with a 3–4 L/min oxygen mask. Laboratory data showed
WBC count of 9000/μl, lymphocyte 11.5%, CRP 10.41 mg/L, and D-dimer 1.5μg/mL, and
chest CT findings showed rapid deterioration. Due to Peggy’s respiratory status, her
physicians deemed of requiring ventilator or ECMO management and an emergency
cesarean section delivery.
On the 5th day of admission, Peggy's fever subsided, but her SpO2 remained at 94%–95%, even with a 10 L/min
oxygen mask. She was subsequently intubated and put on mechanical ventilation at the ICU. The initial
conditions for the mechanical ventilation were as follows: tidal volume 400 mL, respiratory rate 16 breaths/min,
PEEP 15 cm H2O, and FiO2 of 100%. Subsequent ventilator settings and Peggy’s ABG results are as follows:
01
PATHOPHYSIOLOGY
Trace the pathophysiology of the condition and
course of her disease.
Modifiable Factors: Non-Modifiable Factors:
● Positive in RT-PCR swab test ● 30 y/o
● BMI of 27.5 - Overweight ● Female
● Pregnant 34 weeks, Primiparous
RT-PCR
The new viral material is transported to
Positive quantitative throat
the extracellular space
swab for SARS-CoV-2
Laboratory Results:
DAY1
Lymphocyte s- 12.4% -
(Decreased)
Macrophages will detect the new viral Signs and Symptoms
material and release inflammatory DAY1
D-dimer 2.3μg/mL -
mediators Fever - 39.0°C
(Increased)
IL-6487 pg/mL –
(Inceased)
Dilation of endothelial cells of smooth
muscles
Accumulation of fluid plasma into the Neutrophils destroys viral cells inside the
alveoli alveoli (including Type I and Type II cells)
Chest CT Scan
Multifocal ground
The new viral material is transported to Consolidation of the
glass opacities
the extracellular space alveoli
w/partial
consolidation
S/Sx:
Increased work for breathing
Day 2- Dyspnea worsened
Laboratory Result:
DAY 4
Continuous replication, transcription, and
Lymphocytes- 11.5% - S/Sx:
translation of SARS-CoV-2 viral contents;
(Decreased) Day 2 - High fever with chills
release of inflammatory mediators by
and shiver
the macrophages; and loss of type I and
CRP 10.41mg/L - (Increased) Day 5 - Fever subsided
type II cells in alveoli
D-dimer 1.5μg/mL –
(Increased)
S/Sx:
Day 2 - SpO² 95%
Rapid deterioration of lung
Day 4 - Rapidly worsened: SpO²
tissue
94-95%
Day 5 - SpO² remained 94-95%
Covid-19 Pneumonia
02
LABORATORY AND
DIAGNOSTIC TEST
Briefly, but thoroughly, describe and explain each the
laboratory and diagnostic procedures, including the
relevance of each in managing the patient.
CHEST CT-SCAN
Chest Computed Tomography of the lungs are sensitive
and moderately specific in diagnosing COVID-19 thus, may have
more utility for ruling out COVID-19 than for differentiating
SARS-CoV-2 infection from other causes of respiratory illness
(Ebrahimzadeh, 2022).
RESULT
Relevance to the patient:
3.54 mg/L then CRP provides significant clinical
decreased by evaluation index for this can reflect the
10.41 mg/L extent of lung lesion and disease severity
in early stage of COVID-19.
LYMPHOCYTE
Lymphocyte count is one of features that
helps identify patients with severe Covid-19
(Ghizlane, 2021). During viral infection with
COVID-19, angiotensin converting enzyme
(ACE2) is a main receptor for Sars-Cov-2 as
well as Sars-CoV-2, this enzyme used by the
virus to enter the host and caused damage in
lymphoid organ (Leng, 2020).
RESULT
Relevance to the patient:
Lymphocyte
Lymphocytopenia is a dependable marker
12.4% upon
admission then of early SARS CoV-2 contamination and
became 11.5% helps in following of contacts other than
evaluation of sickness movement along
the course of COVID -19 Pneumonia.
WBC
A white blood cell is a type of blood cell that is produced in the
bone marrow and found in the blood and lymph tissue. White blood
cells are components of the immune system. They aid the body's
defense against infection and other diseases. Granulocytes
(neutrophils, eosinophils, and basophils), monocytes, and
lymphocytes are all types of white blood cells (T cells and B cells).
A complete blood cell (CBC) test usually includes a count of white
blood cells in the blood. It can be used to screen for infections,
inflammation, allergies, and leukemia. (Cleveland Clinic, n.d.)
●Teach or include foods that are ●Hard and dry feces may cause trauma
rich in fiber and increase fluid to the mucous membranes of the colon
intake and rectum. Increasing fluid intake and
dietary fiber such as fruits and
vegetables: apple, banana, papaya,
carrots, squash, etc. soften the fecal
mass for easier defecation
A D P INTERVENTION RATIONALE E
S IA L V
S G INDEPENDENT INDEPENDENT A
A ●Monitor hematocrit and hemoglobin regularly as indicated ●Decreased HgB and Hct levels may be an early indicator of
E N N bleeding. L
S O N U
S S ●Monitor the state of the wound ●Helps define the status of the wound and helps identify A
I impediments to the healing process
M I T
N
E S ●Monitor coagulation therapy studies frequently (PTT, PT, INR, ●These values may indicate an increased risk of bleeding. I
N G Platelet count, fibrinogen) as indicated. O
T N
●Obtain type and crossmatch of patients blood. Anticipate the ●To prepare for any need to perform blood transfusion as
need for the patient to have whole blood replacements prescribed. If the blood loss is too much and immediate
correction is warranted, whole blood transfusion administered.
DEPENDENT DEPENDENT
● For bleeding linked with excessive anticoagulant use, ● Protamine sulfate reverses the effect of heparin
give appropriate antidotes as prescribed
COLLABORATIVE COLLABORATIVE
● Refer to the Medical Technologist ● For further inclusion of laboratory findings.
04
DISCHARGE PLAN
MEDICATION
Discharge medications should be explained well before discharge. Discuss with patients the intended effects and possible or expected
side effects of the medication. This will help patients determine whether a medication is working appropriately. It will also help
patients identify undesired side effects that may require intervention
DEXAMETHASONE
Women at risk of imminent preterm delivery receive a short course of dexamethasone or betamethasone to accelerate
fetal lung maturation. In a severe COVID-19 condition, such patients must receive a corticosteroid that poses the least
effects on the growing fetus.
Consult the product instructions and your pharmacist for storage details. Keep all medications away from
children and pets.
REMDESIVIR
Remdesivir injection is used to treat coronavirus disease 2019 (COVID-19) in hospitalized patients. It is also
used to treat mild to moderate COVID-19 in non-hospitalized patients who are at high risk for progression to
severe COVID-19
● Get adequate sleep (7-9 hours) helps boost immune system and
preserve energy. Have a supportive pillow that can make it easier to
get rest.
❖ Health Teaching
● · Adhere to the follow-up check-up schedule. It is better to set a reminder in the phone or calendar.
● If experiencing fever, shortness of breath, headache, dizziness, or oxygen saturation below normal
notify the physician.
❖ Diet
● Centers for Disease Control and Prevention. (2022, March 22). What to Do If You Are Sick. CDC.
Retrieved September 15, 2022, from
https://www.cdc.gov/coronavirus/2019-ncov/if-you-are-sick/steps-when-sick.html
● MedlinePlus. (2022, August 5). Severe COVID-19 - discharge. MedlinePlus. Retrieved September 15,
2022, from https://medlineplus.gov/ency/patientinstructions/000978.htm
● PregActive. (2020, October 15). Exercise After A C-Section - MUST KNOW FACTS! PregActive.
Retrieved September 15, 2022, from https://www.pregactive.com/blog/exercise-after-c-section
● Keizer RJ, Huitema AD, Schellens JH, Beijnen JH: Clinical pharmacokinetics of therapeutic monoclonal
antibodies. Clin Pharmacokinet. 2010 Aug;49(8):493-507. doi: 10.2165/11531280-000000000-00000.
● Abdallah H, Hsu JC, Lu P, Fettner S, Zhang X, Douglass W, Bao M, Rowell L, Burmester GR, Kivitz A:
Pharmacokinetic and Pharmacodynamic Analysis of Subcutaneous Tocilizumab in Patients With
Rheumatoid Arthritis From 2 Randomized, Controlled Trials: SUMMACTA and BREVACTA. J Clin
Pharmacol. 2017 Apr;57(4):459-468. doi: 10.1002/jcph.826. Epub 2016 Nov 17.
● Li YH, Tanno M, Itoh T, Yamada H: Role of the monocarboxylic acid transport system in the intestinal
absorption of an orally active beta-lactam prodrug: carindacillin as a model. Int J Pharm. 1999 Nov
30;191(2):151-9.
GROUP 2 RLE NCMB 418